Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Other financing activities (2023 - 2025)

Guardian Pharmacy Services' Other financing activities history spans 3 years, with the latest figure at $376000.0 for Q4 2025.

  • For Q4 2025, Other financing activities fell 42.24% year-over-year to $376000.0; the TTM value through Dec 2025 reached $1.7 million, down 37.6%, while the annual FY2025 figure was $2.0 million, 28.57% down from the prior year.
  • Other financing activities for Q4 2025 was $376000.0 at Guardian Pharmacy Services, down from $1.2 million in the prior quarter.
  • Across five years, Other financing activities topped out at $1.2 million in Q2 2025 and bottomed at $135000.0 in Q1 2025.
  • The 3-year median for Other financing activities is $513500.0 (2024), against an average of $603750.0.
  • The largest annual shift saw Other financing activities soared 85.47% in 2024 before it tumbled 51.44% in 2025.
  • A 3-year view of Other financing activities shows it stood at $351000.0 in 2023, then skyrocketed by 85.47% to $651000.0 in 2024, then plummeted by 42.24% to $376000.0 in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Other financing activities are $376000.0 (Q4 2025), $1.2 million (Q2 2025), and $135000.0 (Q1 2025).